Xcellbio has developed a proprietary cell control system for use in research, drug development and regenerative medicine. The founders discuss their work in the control of tumor cells, stem cells and immune cells. Xcellbio's main focus is the growth of primary human cells outside of the body, which can then be trained to attack disease-causing cells, then returned to the body to eliminate the disease. Their technology is currently in use for cancer research.
